Multimedia Release -- Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy
February 03, 2014 01:00 ET
|
Given Imaging Ltd.
PillCam COLON is the Only Non-Invasive and Radiation-Free Solution for the Approximately 750,000 Patients in the U.S. Who Experience an Incomplete Colonoscopy Each Year
The Company's PillCam COLON...
Given Imaging Announces Results of Special Shareholders' Meeting
January 23, 2014 10:37 ET
|
Given Imaging Ltd.
YOQNEAM, Israel, Jan. 23, 2014 (GLOBE NEWSWIRE) -- Given Imaging Ltd. (Nasdaq:GIVN) announced that at a special shareholders' meeting held today in Yoqneam, Israel, the shareholders of the Company...
Given Imaging Announces Results of Special Shareholders' Meeting
January 02, 2014 07:00 ET
|
Given Imaging Ltd.
YOQNEAM, Israel, Jan. 2, 2014 (GLOBE NEWSWIRE) -- Given Imaging Ltd. (Nasdaq:GIVN) today announced the results of a special shareholders' meeting which was held in Yoqneam, Israel on December 31,...
Photo Release -- Given Imaging Receives Reimbursement Approval for PillCam COLON(R) in Japan Effective January 1, 2014
November 11, 2013 01:00 ET
|
Given Imaging Ltd.
YOQNEAM, Israel, Nov. 11, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that Japan's Central Social...
Given Imaging Reports Third Quarter 2013 Financial Results
November 05, 2013 16:47 ET
|
Given Imaging Ltd.
Third Quarter 2013 Revenues Increase by 10% to a Record $50 Million
PillCam SB Capsules Sales Climb to a Record 63,500 in the Quarter
Third Quarter 2013 GAAP EPS Increases 5% to $0.20, Non-GAAP...
Given Imaging to Host Third Quarter 2013 Financial Results Conference Call on November 6, 2013
October 22, 2013 07:00 ET
|
Given Imaging Ltd.
YOQNEAM, Israel, Oct. 22, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN) today announced that the company will host a conference call on Wednesday, November 6, 2013 at 9:00am ET, 4:00pm Israel...
Given Imaging Announces the Results of Two Recent Studies Underscoring the Economic Value and Clinical Utility of PillCam(R) ESO in Managing Upper GI Bleeding in the Emergency Department Setting
October 21, 2013 12:30 ET
|
Given Imaging Ltd.
- Cost analysis shows PillCam ESO saves more than $10,000 versus a scoring-based risk stratification strategy for patients at low risk -
- PillCam ESO is significantly more effective than...
Studies Presented at ACG Confirm the Use of Given Imaging's High Resolution Manometry and Reflux Products to Measure Esophageal Dysfunction and Symptom Severity Leading to Altered Disease Management
October 16, 2013 07:01 ET
|
Given Imaging Ltd.
SAN DIEGO, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced results from multiple studies that...
New Data Confirm Given Imaging's Reflux and Manometry Monitoring Products Improve Detection & Management of GERD and Other Esophageal Disorders
October 16, 2013 01:01 ET
|
Given Imaging Ltd.
BERLIN, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced numerous studies confirming the value...
Given Imaging Announces Data Confirming PillCam(R) SB Can Improve Management and Outcomes in Patients With Crohn's Disease
October 15, 2013 07:01 ET
|
Given Imaging Ltd.
SAN DIEGO, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced new studies validating PillCam SB's...